D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 41 Citations 8,794 98 World Ranking 3300 National Ranking 1317

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Bacteria
  • Internal medicine

His primary scientific interests are in Microbiology, Pseudomonas aeruginosa, Virulence, Secretion and Type three secretion system. Alan R. Hauser has researched Microbiology in several fields, including Genetics, Virology, Intensive care, Genotype and Pseudomonadales. His Pseudomonas aeruginosa study combines topics in areas such as Gene, Prophage, Programmed cell death and Effector.

As a part of the same scientific study, Alan R. Hauser usually deals with the Effector, concentrating on Pathogenesis and frequently concerns with Pseudomonas, Cell biology, Bacteria and Chromosomal translocation. In his study, Fimbriae Proteins, Pilus retraction and Pilus is strongly linked to Mutant, which falls under the umbrella field of Virulence. His Secretion research includes elements of Internalization, Arginine, Cytoskeleton and Actin.

His most cited work include:

  • The type III secretion system of Pseudomonas aeruginosa : infection by injection (557 citations)
  • Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. (345 citations)
  • Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. (324 citations)

What are the main themes of his work throughout his whole career to date?

Alan R. Hauser focuses on Microbiology, Pseudomonas aeruginosa, Virulence, Immunology and Type three secretion system. His Microbiology research integrates issues from Secretion, Gene, Whole genome sequencing and Effector. His work is dedicated to discovering how Secretion, Pathogenesis are connected with Disease and other disciplines.

His Pseudomonas aeruginosa course of study focuses on Mutant and Molecular biology. In his work, Efflux is strongly intertwined with Cystic fibrosis, which is a subfield of Immunology. His Type three secretion system research incorporates themes from Pseudomonadaceae and Cell biology.

He most often published in these fields:

  • Microbiology (62.24%)
  • Pseudomonas aeruginosa (49.65%)
  • Virulence (28.67%)

What were the highlights of his more recent work (between 2017-2021)?

  • Microbiology (62.24%)
  • Pseudomonas aeruginosa (49.65%)
  • Bacteria (12.59%)

In recent papers he was focusing on the following fields of study:

His main research concerns Microbiology, Pseudomonas aeruginosa, Bacteria, Virulence and Whole genome sequencing. His Microbiology research incorporates elements of Secretion, Klebsiella pneumoniae and Gene. The study incorporates disciplines such as Pathogen, Genome, Type three secretion system, Phylogenetics and Effector in addition to Pseudomonas aeruginosa.

His work investigates the relationship between Bacteria and topics such as Escherichia coli that intersect with problems in Cell, Cytoplasm, Nucleic acid and Bacterial cell structure. His Virulence study deals with Comparative genomics intersecting with Growth inhibition and Contact inhibition. The various areas that Alan R. Hauser examines in his Whole genome sequencing study include Strain, Viral load and Virology.

Between 2017 and 2021, his most popular works were:

  • A Unique Clade of SARS-CoV-2 Viruses is Associated with Lower Viral Loads in Patient Upper Airways. (39 citations)
  • A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways. (23 citations)
  • A Review of the Clinical Pharmacokinetics of Polymyxin B (20 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The type III secretion system of Pseudomonas aeruginosa : infection by injection

Alan R. Hauser.
Nature Reviews Microbiology (2009)

816 Citations

Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.

Heather Feltman;Grant Schulert;Salman Khan;Manu Jain.
Microbiology (2001)

492 Citations

Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression.

James M. Musser;Alan R. Hauser;Michael H. Kim;Patrick M. Schlievert.
Proceedings of the National Academy of Sciences of the United States of America (1991)

471 Citations

Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa.

Alan R. Hauser;Enesha Cobb;Maria Bodí;Dolors Mariscal.
Critical Care Medicine (2002)

444 Citations

Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis

Alan R. Hauser;Manu Jain;Maskit Bar-Meir;Susanna A. McColley.
Clinical Microbiology Reviews (2011)

405 Citations

Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s.

P. P. Cleary;P. M. Schlievert;J. P. Handley;Michael H Kim.
The Lancet (1992)

398 Citations

Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung

Ciara M. Shaver;Alan R. Hauser.
Infection and Immunity (2004)

369 Citations

Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome.

A R Hauser;D L Stevens;E L Kaplan;P M Schlievert.
Journal of Clinical Microbiology (1991)

287 Citations

Pseudomonas aeruginosa gene products PilT and PilU are required for cytotoxicity in vitro and virulence in a mouse model of acute pneumonia

James C. Comolli;Alan R. Hauser;Leslie Waite;Cynthia B. Whitchurch.
Infection and Immunity (1999)

279 Citations

The Accessory Genome of Pseudomonas aeruginosa

Vanderlene L. Kung;Egon A. Ozer;Alan R. Hauser.
Microbiology and Molecular Biology Reviews (2010)

278 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Alan R. Hauser

James M. Musser

James M. Musser

Houston Methodist

Publications: 79

David J. Evans

David J. Evans

Touro University California

Publications: 52

Scott A. Rice

Scott A. Rice

Nanyang Technological University

Publications: 45

Patrick M. Schlievert

Patrick M. Schlievert

University of Iowa

Publications: 44

Dara W. Frank

Dara W. Frank

Medical College of Wisconsin

Publications: 41

Suzanne M. J. Fleiszig

Suzanne M. J. Fleiszig

University of California, Berkeley

Publications: 36

Staffan Kjelleberg

Staffan Kjelleberg

Nanyang Technological University

Publications: 35

Joanne N. Engel

Joanne N. Engel

University of California, San Francisco

Publications: 34

Burkhard Tümmler

Burkhard Tümmler

Hannover Medical School

Publications: 30

Stephen Lory

Stephen Lory

Harvard University

Publications: 28

Antonio Oliver

Antonio Oliver

Instituto de Salud Carlos III

Publications: 27

Alain Filloux

Alain Filloux

Imperial College London

Publications: 26

Joseph T. Barbieri

Joseph T. Barbieri

Medical College of Wisconsin

Publications: 24

Victor Nizet

Victor Nizet

University of California, San Diego

Publications: 24

Jordi Rello

Jordi Rello

Instituto de Salud Carlos III

Publications: 23

Craig Winstanley

Craig Winstanley

University of Liverpool

Publications: 22

Trending Scientists

Nidal Abu-Hamdeh

Nidal Abu-Hamdeh

King Abdulaziz University

Paul A. Dayton

Paul A. Dayton

University of North Carolina at Chapel Hill

Jang Wook Choi

Jang Wook Choi

Seoul National University

Miguel Ángel Alonso-Díaz

Miguel Ángel Alonso-Díaz

National Autonomous University of Mexico

Thomas Maciag

Thomas Maciag

Maine Medical Center

John Westwick

John Westwick

Novartis (Switzerland)

Derrick E. Fouts

Derrick E. Fouts

J. Craig Venter Institute

Gerald Heckel

Gerald Heckel

University of Bern

Claude R. Duguay

Claude R. Duguay

University of Waterloo

Peter E. Levy

Peter E. Levy

University of Edinburgh

R. Scott Summers

R. Scott Summers

University of Colorado Boulder

Srikantan S. Nagarajan

Srikantan S. Nagarajan

University of California, San Francisco

Kristen Harrison

Kristen Harrison

University of Michigan–Ann Arbor

Alfred Mahr

Alfred Mahr

Université Paris Cité

Carsten Bokemeyer

Carsten Bokemeyer

Universität Hamburg

Joel S. Weissman

Joel S. Weissman

Brigham and Women's Hospital

Something went wrong. Please try again later.